Pfizer enters Gaucher disease market

Pfizer has gained FDA approval for its new Gaucher disease drug Elelyso.  Elelyso (taliglucerase alfa) is an enzyme replacement therapy that is injected twice- monthly, and is now available in th…
Read the full story: InPharm